Literature DB >> 22770694

Regional inequalities in cancer care persist in Italy and can influence survival.

Milena Sant1, Pamela Minicozzi, Claudia Allemani, Claudia Cirilli, Massimo Federico, Riccardo Capocaccia, Mario Budroni, Pina Candela, Emanuele Crocetti, Fabio Falcini, Stefano Ferretti, Mario Fusco, Adriano Giacomin, Francesco La Rosa, Lucia Mangone, Maurilio Natali, Maurizio Ponz De Leon, Adele Traina, Rosario Tumino, Paola Zambon.   

Abstract

BACKGROUND: Population-based cancer registry studies of care patterns can help elucidate reasons for the marked geographic variation in cancer survival across Italy. The article provides a snapshot of the care delivered to cancer patients in Italy.
METHODS: Random samples of adult patients with skin melanoma, breast, colon and non-small cell lung cancers diagnosed in 2003-2005 were selected from 14 Italian cancer registries. Logistic models estimated odds of receiving standard care (conservative surgery plus radiotherapy for early breast cancer; surgery plus chemotherapy for Dukes C colon cancer; surgery for lung cancer; sentinel node biopsy for >1mm melanoma, vs. other treatment) in each registry compared to the entire sample (reference).
RESULTS: Stage at diagnosis for breast, colon and melanoma was earlier in north/central than southern registries. Odds of receiving standard care were lower than reference in Sassari (0.68, 95%CI 0.51-0.90) and Napoli (0.48, 95%CI 0.35-0.67) for breast cancer; did not differ across registries for Dukes C colon cancer; were higher in Romagna (3.77, 95%CI 1.67-8.50) and lower in Biella (0.38, 95%CI 0.18-0.82) for lung cancer; and were higher in Reggio Emilia (2.37, 95%CI 1.12-5.02) and lower in Ragusa (0.27, 95%CI 0.14-0.54) for melanoma.
CONCLUSIONS: Notwithstanding limitations due to variations in the availability of clinical information and differences in stage distribution between north/central and southern registries, our study shows that important disparities in cancer care persist across Italy. Thus the public health priority of reducing cancer survival disparities will not be achieved in the immediate future.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22770694     DOI: 10.1016/j.canep.2012.06.006

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  9 in total

1.  The burden of breast cancer from China to Italy.

Authors:  Alessia Levaggi; Francesca Poggio; Matteo Lambertini
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

Review 2.  Research in cancer care disparities in countries with universal healthcare: mapping the field and its conceptual contours.

Authors:  Christina Sinding; Rachel Warren; Donna Fitzpatrick-Lewis; Jonathan Sussman
Journal:  Support Care Cancer       Date:  2014-08-14       Impact factor: 3.603

3.  A catalyst for change: the European cancer Patient's Bill of Rights.

Authors:  Mark Lawler; Thierry Le Chevalier; Martin J Murphy; Ian Banks; Pierfranco Conte; Francesco De Lorenzo; Françoise Meunier; H M Pinedo; Peter Selby; Jean-Pierre Armand; Mariano Barbacid; Michèle Barzach; Jonas Bergh; Gerlind Bode; David A Cameron; Filippo de Braud; Aimery de Gramont; Volker Diehl; Sarper Diler; Sema Erdem; John M Fitzpatrick; Jan Geissler; Donal Hollywood; Liselotte Højgaard; Denis Horgan; Jacek Jassem; Peter W Johnson; Peter Kapitein; Joan Kelly; Sandra Kloezen; Carlo La Vecchia; Bob Löwenberg; Kathy Oliver; Richard Sullivan; Josep Tabernero; Cornelis J Van de Velde; Nils Wilking; Roger Wilson; Christoph Zielinski; Harald Zur Hausen; Patrick G Johnston
Journal:  Oncologist       Date:  2014-02-03

4.  Breast cancer screening: evidence of benefit depends on the method used.

Authors:  Philippe Autier; Mathieu Boniol
Journal:  BMC Med       Date:  2012-12-12       Impact factor: 8.775

5.  Factors related to breast cancer detection mode and time to diagnosis in Alberta, Canada: a population-based retrospective cohort study.

Authors:  Yan Yuan; Maoji Li; Jing Yang; Tracy Elliot; Kelly Dabbs; James A Dickinson; Stacey Fisher; Marcy Winget
Journal:  BMC Health Serv Res       Date:  2016-02-19       Impact factor: 2.655

6.  Out-of-pocket costs for cancer survivors between 5 and 10 years from diagnosis: an Italian population-based study.

Authors:  Paolo Baili; Francesca Di Salvo; Francesco de Lorenzo; Francesco Maietta; Carmine Pinto; Vera Rizzotto; Massimo Vicentini; Paolo Giorgi Rossi; Rosario Tumino; Patrizia Concetta Rollo; Giovanna Tagliabue; Paolo Contiero; Pina Candela; Tiziana Scuderi; Elisabetta Iannelli; Stefano Cascinu; Fulvio Aurora; Roberto Agresti; Alberto Turco; Milena Sant; Elisabetta Meneghini; Andrea Micheli
Journal:  Support Care Cancer       Date:  2015-11-16       Impact factor: 3.359

7.  Machine-learning prediction of cancer survival: a retrospective study using electronic administrative records and a cancer registry.

Authors:  Sunil Gupta; Truyen Tran; Wei Luo; Dinh Phung; Richard Lee Kennedy; Adam Broad; David Campbell; David Kipp; Madhu Singh; Mustafa Khasraw; Leigh Matheson; David M Ashley; Svetha Venkatesh
Journal:  BMJ Open       Date:  2014-03-17       Impact factor: 2.692

8.  Socioeconomic deprivation worsens the outcomes of Italian women with hormone receptor-positive breast cancer and decreases the possibility of receiving standard care.

Authors:  Francesca Di Salvo; Nicola Caranci; Teresa Spadea; Nicolas Zengarini; Pamela Minicozzi; Hade Amash; Mario Fusco; Fabrizio Stracci; Fabio Falcini; Claudia Cirilli; Giuseppina Candela; Rosanna Cusimano; Rosario Tumino; Milena Sant
Journal:  Oncotarget       Date:  2017-07-22

9.  Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: protocol paper for a mixed methods study.

Authors:  Frances Rapport; Andrea L Smith; Anne E Cust; Graham J Mann; Caroline G Watts; David E Gyorki; Michael Henderson; Angela M Hong; John W Kelly; Georgina V Long; Victoria J Mar; Rachael L Morton; Robyn Pm Saw; Richard A Scolyer; Andrew J Spillane; John F Thompson; Jeffrey Braithwaite
Journal:  BMJ Open       Date:  2020-02-27       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.